Supplementary Materials

The PDF file includes:

  • Materials and Methods
  • Fig. S1. Characterization of lipoaspirate-derived MSCs in vitro.
  • Fig. S2. Inhibition of T cell proliferation by HUCPVC.
  • Fig. S3. Characterization of lipoaspirate-derived MSCs in vivo.
  • Fig. S4. AUC glucose 6 weeks after transplant.
  • Fig. S5. Glucose concentrations after removal of kidney islet graft by nephrectomy.
  • Fig. S6. Immunofluorescence analysis with endothelial marker ERG.
  • Fig. S7. Vessel density in islet grafts with and without HUCPVCs.
  • Fig. S8. Histological assessment of cell infiltrate into liver after syngeneic islet grafts ± HUCPVC.
  • Fig. S9. Liver function 6 weeks after transplant.
  • Table S1. Human islet preparation and associated clinical characteristics.
  • Table S2. GSIS and OCR of islet preparations.
  • Table S3. Glucose concentrations and weights before surgery.
  • References (6471)

[Download PDF]

Other Supplementary Material for this manuscript includes the following: